Further to our intimation dated October 28, 2022, on the Pre-Approval Inspection (PAI) conducted by the United States Food & Drug Administration (USFDA) at our manufacturing facility at Unit-5, Parawada, Visakhapatnam, Andhra Pradesh from 24th October 2022 to 28th October 2022, we wish to inform you that the Company has received the Establishment Inspection Report (EIR) from USFDA. This is for your information and record.